These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 22583806)
1. Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion. Toussaint LG; Nilson AE; Goble JM; Ballman KV; James CD; Lefranc F; Kiss R; Uhm JH Mol Cancer; 2012 May; 11():32. PubMed ID: 22583806 [TBL] [Abstract][Full Text] [Related]
2. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640 [TBL] [Abstract][Full Text] [Related]
3. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Rorive S; Belot N; Decaestecker C; Lefranc F; Gordower L; Micik S; Maurage CA; Kaltner H; Ruchoux MM; Danguy A; Gabius HJ; Salmon I; Kiss R; Camby I Glia; 2001 Mar; 33(3):241-55. PubMed ID: 11241742 [TBL] [Abstract][Full Text] [Related]
4. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients. Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650 [TBL] [Abstract][Full Text] [Related]
6. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells. Huang J; Chen K; Chen J; Gong W; Dunlop NM; Howard OM; Gao Y; Bian XW; Wang JM Br J Cancer; 2010 Mar; 102(6):1052-60. PubMed ID: 20197768 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
9. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin. Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase. Gao Y; Fotovati A; Lee C; Wang M; Cote G; Guns E; Toyota B; Faury D; Jabado N; Dunn SE Mol Cancer Ther; 2009 Dec; 8(12):3276-84. PubMed ID: 19996271 [TBL] [Abstract][Full Text] [Related]
18. GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway. Yu S; Yu X; Sun L; Zheng Y; Chen L; Xu H; Jin J; Lan Q; Chen CC; Li M Oncogene; 2020 Jul; 39(27):5042-5055. PubMed ID: 32518375 [TBL] [Abstract][Full Text] [Related]
19. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041 [TBL] [Abstract][Full Text] [Related]
20. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. Camby I; Belot N; Lefranc F; Sadeghi N; de Launoit Y; Kaltner H; Musette S; Darro F; Danguy A; Salmon I; Gabius HJ; Kiss R J Neuropathol Exp Neurol; 2002 Jul; 61(7):585-96. PubMed ID: 12125737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]